Food and Drug Administration

Blood Products Advisory Committee

July 21, 2005

Briefing Information

Topic 1: FDA's Current Considerations on the Management of Whole Blood and source Plasma Donors and Units When a Donor Tests Positive for Hepatitis B Virus (HBV) DNA by a Nucleic Acid Test (NAT) (HTM) (PDF) (Word)

Topic 2: Scientific Basis for Review of Varicella Zoster Immune Globulin (HTM) (PDF) (Word)

Topic 2 References (HTM) (PDF) (Word)

Topic 3: Prophylaxis of Dextran-Induced Anaphylactoid Reactions (DIAR) by Dextran 1 Pre-Administration (HTM) (PDF) (Word)